GrubMarket vs SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma: Revenue, Funding & Team Size Compared
GrubMarket generates $2.4B in revenue; SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma has not disclosed its revenue. The table below compares GrubMarket and SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $2.4B | Not disclosed |
| Valuation | $3.5B | Not disclosed |
| Funding raised | $515M | Not disclosed |
| Team size | 115 | Not disclosed |
| Growth | 20% | Not disclosed |
| Founded | 2014 | Not disclosed |
| HQ | San Francisco, United States | Wiesbaden, Germany |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GrubMarket at a glance
GrubMarket generates $2.4B in revenue with 115 employees, headquartered in San Francisco, United States.
- Revenue
- $2.4B
- Valuation
- $3.5B
- Funding
- $515M
- Team size
- 115
- Founded
- 2014
AI-powered technology enabler and digital transformer of American…
SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma at a glance
SynapCon develops & distributes software for clinical trials, making the process faster, better and more cost-effective.
Other GrubMarket alternatives
GrubMarket competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GrubMarket vs SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma: frequently asked questions
How much revenue does GrubMarket make?
GrubMarket generates $2.4B in annual revenue with a team of 115.
How much funding has GrubMarket raised?
GrubMarket has raised $515M in total funding since it was founded in 2014.